153 related articles for article (PubMed ID: 24861354)
1. Current status of prenatal diagnosis in Cuba: causes of low prevalence of Down syndrome.
Méndez-Rosado LA; Hechavarría-Estenoz D; de la Torre ME; Pimentel-Benitez H; Hernández-Gil J; Perez B; Barrios-Martínez A; Morales-Rodriguez E; Soriano-Torres M; Garcia M; Suarez-Mayedo U; Cedeño-Aparicio N; Blanco I; Díaz-Véliz P; Vidal-Hernández B; Mitjans-Torres M; Miñoso S; Alvarez-Espinosa D; Reyes-Hernández E; Angulo-Cebada E; Torres-Palacios M; Lozano-Lezcano L; Lima-Rodriguez U; Mayeta M; Noblet M; Benítez Y; Lardoeyt-Ferrer R; Yosela-Martin S; Carbonell P; Pérez-Ramos M; de León N; Perez M; Carbonell J
Prenat Diagn; 2014 Nov; 34(11):1049-54. PubMed ID: 24861354
[TBL] [Abstract][Full Text] [Related]
2. The impact of maternal serum screening on the birth prevalence of Down's syndrome and the use of amniocentesis and chorionic villus sampling in South Australia.
Cheffins T; Chan A; Haan EA; Ranieri E; Ryall RG; Keane RJ; Byron-Scott R; Scott H; Gjerde EM; Nguyen AM; Ford JH; Sykes S
BJOG; 2000 Dec; 107(12):1453-9. PubMed ID: 11192100
[TBL] [Abstract][Full Text] [Related]
3. Gradual implementation of first trimester screening in a population with a prior screening strategy: population based cohort study.
Calda P; Sípek A; Gregor V
Acta Obstet Gynecol Scand; 2010 Aug; 89(8):1029-33. PubMed ID: 20524903
[TBL] [Abstract][Full Text] [Related]
4. Prenatal diagnosis of trisomy 21: registration results from a single genetic center.
Witters I; Fryns JP
Genet Couns; 2008; 19(2):157-63. PubMed ID: 18618989
[TBL] [Abstract][Full Text] [Related]
5. Prenatal testing for Down syndrome in the Jewish and non-Jewish populations in Israel.
Davidov B; Goldman B; Akstein E; Barkai G; Legum C; Dar H; Romem Y; Amiel A; Cohen H; Bach G
Isr J Med Sci; 1994 Aug; 30(8):629-33. PubMed ID: 8045747
[TBL] [Abstract][Full Text] [Related]
6. [Invasive prenatal diagnosis in the Netherlands, 1991-2000: number of procedures, indications and abnormal results detected].
Nagel HT; Knegt AC; Kloosterman MD; Wildschut HI; Leschot NJ; Vandenbussche FP
Ned Tijdschr Geneeskd; 2004 Jul; 148(31):1538-43. PubMed ID: 15366724
[TBL] [Abstract][Full Text] [Related]
7. The population impact of screening for Down syndrome: audit of 19 326 invasive diagnostic tests in England and Wales in 2008.
Morris JK; Waters JJ; de Souza E
Prenat Diagn; 2012 Jun; 32(6):596-601. PubMed ID: 22573430
[TBL] [Abstract][Full Text] [Related]
8. Maternal age-specific fetal loss rates in Down syndrome pregnancies.
Savva GM; Morris JK; Mutton DE; Alberman E
Prenat Diagn; 2006 Jun; 26(6):499-504. PubMed ID: 16634111
[TBL] [Abstract][Full Text] [Related]
9. The evolving national birth prevalence of Down syndrome in Taiwan. A study on the impact of second-trimester maternal serum screening.
Jou HJ; Kuo YS; Hsu JJ; Shyu MK; Hsieh TT; Hsieh FJ
Prenat Diagn; 2005 Aug; 25(8):665-70. PubMed ID: 16049991
[TBL] [Abstract][Full Text] [Related]
10. Impact of introducing a national policy for prenatal Down syndrome screening on the diagnostic invasive procedure rate in England.
Morgan S; Delbarre A; Ward P
Ultrasound Obstet Gynecol; 2013 May; 41(5):526-9. PubMed ID: 23297122
[TBL] [Abstract][Full Text] [Related]
11. Down syndrome: effects of demographic factors and prenatal diagnosis on the future livebirth prevalence.
Cornel MC; Breed AS; Beekhuis JR; te Meerman GJ; ten Kate LP
Hum Genet; 1993 Sep; 92(2):163-8. PubMed ID: 8370583
[TBL] [Abstract][Full Text] [Related]
12. Are age cutoffs still used to identify candidates for invasive testing for chromosomal abnormalities?
Wasden SW; Adams BN; Chasen ST
J Reprod Med; 2011; 56(3-4):113-6. PubMed ID: 21542527
[TBL] [Abstract][Full Text] [Related]
13. A retrospective analysis of amniocenteses performed for advanced maternal age and various other indications in Turkish women.
Danisman N; Kahyaoglu S; Celen S; Kahyaoglu I; Candemir Z; Yesilyurt A; Cakar ES
J Matern Fetal Neonatal Med; 2013 Feb; 26(3):242-5. PubMed ID: 23025698
[TBL] [Abstract][Full Text] [Related]
14. Recent trends in the birth prevalence of Down syndrome in China: impact of prenatal diagnosis and subsequent terminations.
Deng C; Yi L; Mu Y; Zhu J; Qin Y; Fan X; Wang Y; Li Q; Dai L
Prenat Diagn; 2015 Apr; 35(4):311-8. PubMed ID: 25315427
[TBL] [Abstract][Full Text] [Related]
15. Prenatal invasive testing: a 13-year single institution experience.
Comas C; Echevarria M; Rodríguez I; Serra B; Cirigliano V
J Matern Fetal Neonatal Med; 2014 Aug; 27(12):1209-12. PubMed ID: 24131234
[TBL] [Abstract][Full Text] [Related]
16. [Trisomy 21 and its prenatal detection in the Canton of Vaud (1980-1996)].
Pescia G; Addor MC
Schweiz Med Wochenschr; 2000 Sep; 130(38):1332-8. PubMed ID: 11064925
[TBL] [Abstract][Full Text] [Related]
17. Changes in the utilization of prenatal diagnosis.
Benn PA; Egan JF; Fang M; Smith-Bindman R
Obstet Gynecol; 2004 Jun; 103(6):1255-60. PubMed ID: 15172861
[TBL] [Abstract][Full Text] [Related]
18. Down syndrome prevention program in a population with an older maternal age.
Shohat M; Legum C; Romem Y; Borochowitz Z; Bach G; Goldman B
Obstet Gynecol; 1995 Mar; 85(3):368-73. PubMed ID: 7862374
[TBL] [Abstract][Full Text] [Related]
19. Current French practices for prenatal diagnosis of trisomy 21: a population-based study in Paris, 1992-97.
De Vigan C; Vodovar V; Vérité V; Dehé S; Goujard J
Prenat Diagn; 1999 Dec; 19(12):1113-8. PubMed ID: 10590427
[TBL] [Abstract][Full Text] [Related]
20. [Prenatal diagnosis of chromosome aberrations after implementation of screening for Down's syndrome].
Kjaergaard S; Hahnemann JM; Skibsted L; Jensen LN; Sperling L; Zingenberg H; Kristiansen A; Brøndum-Nielsen K
Ugeskr Laeger; 2008 Mar; 170(14):1152-6. PubMed ID: 18405480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
